AUA

PROSPER: Enzalutamide Benefit in Nonmetastatic CRPC?
May 22, 2018

A new analysis of PROSPER, presented at AUA 2018, suggests enzalutamide plus ADT may be superior to ADT alone in nonmetastatic CRPC.